Convergent evidence now implicates disturbed Cl− regulation in multiple neurological disorders—including epilepsy, AD, ASD, HD, and neuropathic pain—via dysfunction or misregulation of key Cl− channels and transporters (e.g., GABAA/glycine receptors, NKCC1, KCC2). The gene discussed is SLC12A2; the disease is nervous system disorder.